BridgeBio Pharma (BBIO) EBIT Growth (1y) (2019 - 2026)
BridgeBio Pharma (BBIO) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 2,150.96% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 145.20% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn | -1.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.52% |
| Dec 31, 2025 | 38.25% |
| Sep 30, 2025 | 24.28% |
| Jun 30, 2025 | 23.51% |
| Mar 31, 2025 | -30,529.15% |
| Dec 31, 2024 | -27.40% |
| Sep 30, 2024 | -21.60% |
| Jun 30, 2024 | -20.15% |
| Mar 31, 2024 | 100.27% |
| Dec 31, 2023 | -37.28% |
| Sep 30, 2023 | -22.13% |
| Jun 30, 2023 | -82.22% |
| Mar 31, 2023 | 27.36% |
| Dec 31, 2022 | 21.97% |
| Sep 30, 2022 | 13.63% |
| Jun 30, 2022 | 14.72% |
| Mar 31, 2022 | -3.69% |
| Dec 31, 2021 | -29.90% |
| Sep 30, 2021 | -24.65% |
| Jun 30, 2021 | 24.53% |